111 Price to Free Cash Flow Ratio 2018-2024 | YI
Historical price to free cash flow ratio values for 111 (YI) since 2018.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| 111 Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-06-20 | 8.00 | 2.02 | |
| 2024-12-31 | 6.23 | $3.96 | 1.57 |
| 2024-09-30 | 7.56 | $1.61 | 4.69 |
| 2024-06-30 | 10.65 | $0.31 | 33.99 |
| 2024-03-31 | 11.60 | $-3.74 | 0.00 |
| 2023-12-31 | 15.50 | $-7.61 | 0.00 |
| 2023-09-30 | 26.00 | $-3.53 | 0.00 |
| 2023-06-30 | 24.60 | $-3.86 | 0.00 |
| 2023-03-31 | 26.50 | $-1.75 | 0.00 |
| 2022-12-31 | 30.20 | $-0.93 | 0.00 |
| 2022-09-30 | 26.80 | $-8.66 | 0.00 |
| 2022-06-30 | 20.60 | $-10.97 | 0.00 |
| 2022-03-31 | 26.60 | $-10.72 | 0.00 |
| 2021-12-31 | 35.00 | $-14.21 | 0.00 |
| 2021-09-30 | 61.70 | $-10.35 | 0.00 |
| 2021-06-30 | 90.85 | $-7.88 | 0.00 |
| 2021-03-31 | 138.00 | $-5.50 | 0.00 |
| 2020-12-31 | 69.50 | $-2.64 | 0.00 |
| 2020-09-30 | 62.00 | $-1.13 | 0.00 |
| 2020-06-30 | 63.50 | $-6.38 | 0.00 |
| 2020-03-31 | 66.10 | $-10.18 | 0.00 |
| 2019-12-31 | 67.30 | $-9.34 | 0.00 |
| 2019-09-30 | 48.70 | $-12.89 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.069B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.769B | 58.23 |
| Hims & Hers Health (HIMS) | United States | $14.374B | 149.35 |
| Tempus AI (TEM) | United States | $11.826B | 0.00 |
| Doximity (DOCS) | United States | $10.774B | 49.88 |
| IRhythm Technologies (IRTC) | United States | $4.653B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.861B | 60.33 |
| Hinge Health (HNGE) | United States | $3.282B | 0.00 |
| Privia Health (PRVA) | United States | $2.664B | 182.08 |
| Enovis (ENOV) | United States | $1.720B | 9.59 |
| Phreesia (PHR) | United States | $1.560B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Schrodinger (SDGR) | United States | $1.501B | 0.00 |
| Azenta (AZTA) | United States | $1.357B | 63.06 |
| 10x Genomics (TXG) | United States | $1.331B | 0.00 |
| Omnicell (OMCL) | United States | $1.313B | 23.17 |
| Evolent Health (EVH) | United States | $1.086B | 92.50 |
| Claritev (CTEV) | United States | $0.657B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.514B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.448B | 134.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.337B | 746.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.251B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.156B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| CareCloud (CCLD) | United States | $0.106B | 4.03 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.094B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |